Coegin Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-28.08	-27.98	-35.24	-27.15	-46.24
Depreciation & Amortization	3.02	3.02	2.72	0.01	0.02
Other Operating Activities	0.01	0.01	-	-	37.14
Change in Accounts Receivable	2.73	2.49	1.52	-2.18	2.36
Change in Other Net Operating Assets	1.69	0.44	-7.24	7.83	-1.06
Operating Cash Flow	-20.63	-22.02	-38.23	-21.49	-7.78
Cash Acquisitions	-	-	12.01	-	-
Investing Cash Flow	-	-	12.01	-	-
Long-Term Debt Issued	-	4	4	-	-
Long-Term Debt Repaid	-	-4	-	-	-
Net Debt Issued (Repaid)	0.5	-	4	-	-
Issuance of Common Stock	24.72	26.83	-	31.73	16.93
Other Financing Activities	-2.33	-3.08	-	-2.39	6.93
Financing Cash Flow	22.88	23.75	4	29.35	23.86
Foreign Exchange Rate Adjustments	0.07	-	0.38	1.15	-1.2
Net Cash Flow	2.32	1.73	-21.84	9.01	14.88
Free Cash Flow	-20.63	-22.02	-38.23	-21.49	-7.78
Free Cash Flow Per Share	-2.12	-2.39	-5.57	-3.61	-5.95
Levered Free Cash Flow	-10.54	-11.46	-19.61	-11.33	-
Unlevered Free Cash Flow	-10.32	-11.43	-19.47	-11.33	-
Change in Net Working Capital	-3.93	-2.94	0.51	-5.65	-

Source: S&P Capital IQ. Standard template. Financial Sources.